ASM Microbe Conference

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, sat down with Contagion™ to discuss antimicrobial susceptibility and resistance and new technologies in the field.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses push and pull incentives that drive antibiotic development.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses global and national initiatives for the development of new antibiotics.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the economics of antimicrobial development.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, discusses the economic opportunities driving the development of new pharmaceuticals.

Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the prognosis of babies with Zika-related complications.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses whether or not all Zika-infected pregnant women will infect their fetuses.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the likelihood that fetuses congenitally infected with the Zika virus will develop related complications, such as microcephaly.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the possibility of the Zika virus evolving to cause other complications in the future.

Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, explains how Zika has evolved since the 1960s.

Andrew Chasteen from Accelerate Diagnostics, Inc, explains future applications of Morphokinetic Cellular Analysis (MCA).

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains his research regarding topoisomerase I and II enzymes.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, discusses the advantages of narrow spectrum antibiotics.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains how clinicians can identify pathogenic organisms to determine which narrow spectrum antibiotic to use for treatment.

Justin R. Anderson, PhD, associate professor of biology at Radford University, explains the factors that make some people more susceptible to contracting mosquito-borne viruses.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses what factors will aid mosquito control specialists in eradicating vector populations.

Justin R. Anderson, PhD, associate professor of biology at Radford University, discusses how endocrine disrupting chemicals interact with larvae to change infected mosquitoes.

Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains the difference between topoisomerase I and quinolone antibacterials.

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the goals of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS).

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the need for more research on neonatal infections.

Craig Rubens, MD, PhD, co-founder and executive director of GAPPS at Seattle Children’s Hospital, discusses the importance of understanding the global burden of neonatal death and disease.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses how stewardship recommendations can drive change in how physicians manage their patients.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses the importance of minimizing the gap between clinical trial data and real world outcomes.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains how metals affect the growth of Legionella.

Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, discusses the two approaches used to detect antimicrobial susceptibility: genotypic and phenotypic.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains the danger Legionella poses.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains how the material of water pipes can have public health implications.

Andrea Endimiani, MD, PhD, professor at the Institute for Infectious Diseases at the University of Bern, Switzerland, discusses how antibiotic stewardship can reduce the risk of antimicrobial-resistant superbugs.

Otto Schwake, PhD, Department of Civil and Environmental Engineering at Virginia Tech, lead researcher from the Flint Water Study team, explains why in Flint, Michigan, Legionella prevalence differed based on building size